0001415889-24-016995.txt : 20240614 0001415889-24-016995.hdr.sgml : 20240614 20240614180009 ACCESSION NUMBER: 0001415889-24-016995 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240614 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eldridge George A CENTRAL INDEX KEY: 0001413006 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40544 FILM NUMBER: 241046286 MAIL ADDRESS: STREET 1: C/O TARGANTA THERAPEUTICS CORPORATION STREET 2: 222 THIRD STREET SUITE 2300 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc. CENTRAL INDEX KEY: 0001798749 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831377888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-443-2400 MAIL ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-06142024_060606.xml X0508 4 2024-06-14 0001798749 Aerovate Therapeutics, Inc. AVTE 0001413006 Eldridge George A C/O AEROVATE THERAPEUTICS, INC. 930 WINTER STREET, SUITE M-500 WALTHAM MA 02451 false true false false SEE REMARKS 1 Common Stock 2024-06-14 4 M 0 15000 2.14 A 20022 D Common Stock 2024-06-14 4 S 0 15000 25.03 D 5022 D Stock Option (Right to Buy) 2.14 2024-06-14 4 M 0 15000 0 D 2031-04-01 Common Stock 15000 28763 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023. Includes 3,062 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2024 in a transaction that is exempt under Rule 16b-3(c) and 16b3(d). A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. Officer Title: Chief Financial Officer and Treasurer /s/ George A. Eldridge 2024-06-14